DLM-SF: Amount of Saturated Fat Intake Summary Table (2021)

DLM-SF: Amount of Saturated Fat Intake Summary Table (2021)

Summary of Amount of Saturated Fat Intake and Association with Morbidities and Mortality Evidence Summary  Table 

The following table is a visual representation of evidence from an overview of systematic reviews that evaluated the association of saturated fat intake with morbidities and mortality. Further synthesis can be found on the Amount of Saturated Fat Intake Systematic Review page. 

Outcomes Systematic Reviews Reporting the Outcomes Relative Risk (95% CI*) Number of Participants (Number of Events) Quality of Evidence
All-cause Mortality
   de Souza et al 2015  0.99 (0.91, 1.09)  99,906 (14,090)  Very low
   Harcombe et al 2016  0.996 (0.865,1.147)  2,467 (370)  Not reported
   Hooper et al 2000  0.96 (0.90, 1.03)  55,858 (3,518)  Moderate
 Cardiovascular Disease (CVD) Mortality
   de Souza et al 2015  0.97 (0.84, 1.12)  90,501 (3,792)  Very low
   Hooper et al 2020  0.94 (0.78, 1.13)  53,421 (1,096)  Moderate
 Combined Cardiovascular Disease (CVD) Events
   Hooper et al 2020  0.79 (0.66, 0.93)  53,300 (4,476)  Moderate
 Coronary Heart Disease (CHD) Mortality
   de Souza et al 2015  1.15 (0.97, 1.09)  101,712 (2,970)  Very low
   Harcombe et al 2016  0.989 (0.784, 1.247)  2,467 (223)  Not reported
   Hooper et al 2020  0.97 (0.82, 1.16)  53,159 (927)  Low
 Coronary Heart Disease (CHD) Events
   de Souza et al 2015  1.06 (0.95, 1.17)  267,416 (6,383)  Very low
   Hooper et al 2020  0.83 (0.68, 1.01)  53,199 (2,261)  Very low
 Cerebral Vascular Accident
   de Souza et al 2015  1.02 (0.90, 1.15)  339,090 (6,226)  Very low
   Hooper et al 2020  0.92 (0.68, 1.25)  50,952 (1,118)  Very low
*CI=confidence interval / Blue=no effect; Green=decreased risk